Lv3
210 积分 2023-11-17 加入
Nemolizumab: First Approval
23天前
已完结
Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs
23天前
已完结
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
23天前
已完结
Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations
24天前
已完结
The suitability of treating atopic dermatitis with Janus kinase inhibitors
25天前
已完结
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
25天前
已完结
Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial
29天前
已完结
Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: a 36‐month follow‐up study
29天前
已完结
Role of Co-stimulatory Molecules in T Helper Cell Differentiation
1个月前
已完结
Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements
1个月前
已完结
皖公网安备34019202002308
